Cargando…
SARS-CoV-2 virus: Vaccines in development
The ongoing COVID-19 pandemic, caused by SARS-CoV-2, is an unprecedented challenge to humanity. Global herd immunity may be necessary before resumption of normal economic and societal activities. Since the beginning of the outbreak, the development of COVID-19 vaccines has proceeded at record speed...
Autores principales: | Huang, Qingrui, Yan, Jinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Publishing Services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825979/ http://dx.doi.org/10.1016/j.fmre.2021.01.009 |
Ejemplares similares
-
Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies
por: Huang, Qingrui, et al.
Publicado: (2022) -
Distinct BCR repertoires elicited by SARS-CoV-2 RBD and S vaccinations in mice
por: Tian, Siyu, et al.
Publicado: (2021) -
Development of vaccines for SARS-CoV-2
por: Ng, Wern Hann, et al.
Publicado: (2020) -
The way of SARS-CoV-2 vaccine development: success and challenges
por: Dong, Yetian, et al.
Publicado: (2021) -
A non-ACE2-blocking neutralizing antibody against Omicron-included SARS-CoV-2 variants
por: Duan, Xiaomin, et al.
Publicado: (2022)